Touching tumour‐infiltrating lymphocytes in low‐risk ductal carcinoma in situ (DCIS) correlate with upgrading to high‐grade DCIS

Citations Over TimeTop 20% of 2021 papers

Abstract

Intermediate-grade and touching TILs may be good variables to examine in the COMET trial and to correlate with the risk of upgrading.

Related Papers

• → Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade☆(2010)65 cited
• → Further insights into the Fe(ii) reduction of 2-line ferrihydrite: a semi in situ and in situ TEM study(2020)9 cited
• → The risk of contralateral breast cancer in daughters of women with and without breast cancer(2015)12 cited
• → Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast(1994)17 cited
• The expression of insulin-like growth factor-1 receptor on LN ( - )breast cancer,LN( + )breast cancer and normal breast tissue(2004)